Pharmacotherapy

Papers
(The H4-Index of Pharmacotherapy is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
161
Warfarin dosage in a postpartum woman while breastfeeding: A case report117
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey100
Update and narrative review of avian influenza (H5N1) infection in adult patients90
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy85
Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or R59
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors51
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy50
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review49
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps49
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect44
Correlation Between Analgesic and Sedative Drug Withdrawal and Salivary Cortisol Levels in Children in PICUs : A Prospective Cohort Study42
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorse39
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures37
A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial37
Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation36
35
Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”29
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy27
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)27
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency27
Response to comment on “Dosing implications for liposomal amphotericin B in pregnancy”25
Factors That Influence Blood Pressure Changes With the Use of Sodium‐Glucose Cotransporter 2 Inhibitors in People With Type 2 Diabetes24
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study24
0.046631813049316